ClinicalTrials.Veeva

Menu

The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Total Knee Arthroplasty

Rigshospitalet logo

Rigshospitalet

Status and phase

Completed
Phase 4

Conditions

Knee Arthroplasty
Postoperative Pain

Treatments

Procedure: Adductor-Canal-Blockade with Ropivacaine
Procedure: Adductor-Canal-blockade with saline

Study type

Interventional

Funder types

Other

Identifiers

NCT01261897
2010-021918-30 (EudraCT Number)
SM2-PJ-10

Details and patient eligibility

About

The objective of this study is to assess the efficacy of Adductor-Canal-Blockade on pain and morphine consumption after total knee arthroplasty. Our hypothesis is that the Adductor -Canal-Blockade is superior to placebo in reducing pain and morphine consumption after total knee arthroplasty.

Enrollment

40 estimated patients

Sex

All

Ages

40 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Total Knee Arthroplasty in general anaesthesia
  • ASA 1-3
  • BMI 18-40
  • Written informed consent

Exclusion criteria

  • Can not cooperate to the exam
  • Do not speak or understand Danish
  • Drug allergy
  • Alcohol or drug abuse
  • Daily consumption of strong opioids

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups, including a placebo group

Adductor-Canal-Blockade with Ropivacaine
Active Comparator group
Treatment:
Procedure: Adductor-Canal-Blockade with Ropivacaine
Adductor-Canal-blockade with saline
Placebo Comparator group
Treatment:
Procedure: Adductor-Canal-blockade with saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems